Related Experiment Video
Updated: Jul 11, 2026
07:55
The Influence of Liver Resection on Intrahepatic Tumor Growth
Published on: April 9, 2016
9.5K
So Now We Know-Reflections on the Extent of Resection for Stage I Lung Cancer
Frank Detterbeck1, Sora Ely2, Brooks Udelsman3
1Division of Thoracic Surgery, Department of Surgery, Yale University School of Medicine, New Haven, CT.
Clinical Lung Cancer
|February 3, 2024
Summary
Sublobar resection is a viable alternative to lobectomy for early-stage lung cancer in healthy patients, showing similar short-term outcomes. Long-term results vary, suggesting cautious use for specific tumor types.
Area of Science:
- Thoracic Surgery
- Oncology
- Clinical Trials
Background:
- Lobectomy has been the standard for stage I lung cancer since 1995.
- Recent trials investigate sublobar resection as an alternative.
Purpose of the Study:
- To evaluate the role of sublobar resection versus lobectomy in healthy patients with stage I lung cancer.
- To compare perioperative outcomes, survival, and recurrence rates.
Main Methods:
- Analysis of 4 randomized trials with varying designs and eligibility criteria.
- Inclusion of patients with stage IA or less and adequate resection margins.
Main Results:
- No significant differences in perioperative morbidity, mortality, or lung function changes.
- Inconsistent long-term survival data; 2 trials showed no difference, others favored lobectomy.
- Recurrence-free survival was similar across trials, despite higher local recurrence with sublobar resection.
Conclusions:
- Sublobar resection is a reasonable alternative to lobectomy for select patients.
- Cautious application is advised due to variable long-term results and lack of short-term benefits.
- Careful intraoperative assessment and suitability for less aggressive tumors are crucial.
